Interní Med. 2010; 12(10): 504-505 [Psychiatr. pro Praxi, 2010; 11(3): 125-126]

Intracranial bleeding associated with selective serotonin reuptake inhibitor paroxetine

prof.MUDr.Alexandra Žourková, CSc.
Psychiatrická klinika LF MU a FN Brno

and coadministration with ibuprofen

The observational case report deal with a 48-year old woman who used paroxetine and ibuprofen developed intracranial bleeding.

Paroxetine and ibuprofen synergistically inhibit platelet function. Doctors should be aware of the increased risk of hemorrhage among

patients on selective serotonin reuptake inhibitors.

Keywords: paroxetine, ibuprofen, antiplatelet activity, intracranial bleeding

Published: November 15, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Žourková A. Intracranial bleeding associated with selective serotonin reuptake inhibitor paroxetine. Interní Med. 2010;12(10):504-505.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vrána M, Honzák R. Lze snížit kardiovaskulární riziko při ischemické chorobě srdeční léčbou deprese? Farmakoterapie 2006; 2: 318-322.
    2. de Abajo FJ, Montero D, Rodriguez LA, Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin. Pharmacol. Toxicol. 2006; 98: 304-310. Go to original source... Go to PubMed...
    3. Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin. Neurosci. 2007; 9: 47-59. Go to original source...
    4. Van Cann EM, Koole R. Retrobulbar hematoma associated with selective serotonin reuptake inhibitor: a case report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2009; 108: 1-2. Go to original source... Go to PubMed...
    5. Abdelmalik N, Ruhé HG, Barwari K, et al. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J. Thromb. Haemost. 2008; 6: 2168-2174. Go to original source... Go to PubMed...
    6. Hougardy DM, Egberts TC, van der Graaf, et al. Serotonin transporter polymorphism and bleeding time during SSRI therapy. Br. J. Clin. Pharmacol. 2008; 65: 761-766. Go to original source... Go to PubMed...
    7. Kotzailias N, Andonovski T, Dukic A, et al. Antiplatelete activity during coadministration of the selective serotonin reuptake inhibitor paroxetine and aspirin in male smokers: a randomized, placebo-controlled, double-blind trial. J. Clin. Pharmacol. 2006; 46: 468-475. Go to original source... Go to PubMed...
    8. Hersh EV, Pinto A, Moore PA. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin. Ther. 2007; 29(suppl.): 2477-2497. Go to original source... Go to PubMed...
    9. Rainsford KD. Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology 2009; 17: 275-342. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.